Chalk River Laboratories

Chalk River Laboratories (CRL) is Canada's premier nuclear science and technology facility, operated by Canadian Nuclear Laboratories (CNL) on behalf of Atomic Energy of Canada Limited. It serves as a global leader in the research, development, and production of medical isotopes used in the diagnosis and treatment of cancer and other life-threatening diseases. CRL is a critical node in the radiopharmaceutical supply chain, specializing in the production of high-purity Actinium-225 for Targeted Alpha Therapy (TAT) and Lutetium-177 for radioligand therapy. The facility offers a wide range of services to the biotech and pharmaceutical industries, including isotope processing, radiochemistry research, and preclinical imaging. With its unique nuclear infrastructure, CRL supports the advancement of precision medicine by enabling the development of next-generation radiotherapies. The laboratory continues to expand its capabilities through strategic partnerships aimed at securing the global supply of therapeutic isotopes.